rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Natco Pharma Ltd. - Research Center
524816 NATCOPHARM Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income
Operating income 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30
Expenses
Material consumed 567.10 570.10 528.10 426.00 376.30
Manufacturing expenses 81.90 76.40 59.40 62.40 59.60
Personnel expenses 425.70 410.10 380.00 356.10 340.20
Selling expenses - - - - -
Adminstrative expenses 431.60 498.20 268.40 367.70 393.70
Expenses capitalised - - - - -
Cost of sales 1,506.30 1,554.80 1,235.90 1,212.20 1,169.80
Operating profit 844.70 213.00 417.60 578.00 816.50
Other recurring income 85.50 94.60 101.10 123.80 129.80
Adjusted PBDIT 930.20 307.60 518.70 701.80 946.30
Financial expenses 8.60 13.30 11.30 20.60 18.80
Depreciation 150.90 138.40 115.20 98.10 80.10
Other write offs - - - - -
Adjusted PBT 770.70 155.90 392.20 583.10 847.40
Tax charges 133.60 16.80 82.70 108.60 180.30
Adjusted PAT 637.10 139.10 309.50 474.50 667.10
Non recurring items 1.70 9.80 -0.30 -5.20 -
Other non cash adjustments - - - - -
Reported net profit 638.80 148.90 309.20 469.30 667.10
Earnigs before appropriation 3,225.90 2,668.90 2,631.70 2,476.10 2,138.00
Equity dividend 100.40 82.10 113.90 101.20 73.00
Preference dividend - - - - -
Dividend tax - - - 26.20 18.90
Retained earnings 3,125.50 2,586.80 2,517.80 2,348.70 2,046.10
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close